TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Betulin, Sorafenib
Phytochemical Name Betulin (PubChem CID: 72326 )
Anticancer drug Name Sorafenib (PubChem CID: 216239 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 688
Pair Name Betulin, Sorafenib
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Inhibition-->Glycolysis
Gene Regulation Up-regulation Expression SREBF1 hsa6720
In Vitro Model Hep-G2 Hepatoblastoma Homo sapiens (Human) CVCL_0027
Huh-7 Adult hepatocellular carcinoma Homo sapiens (Human) CVCL_0336
SMMC-7721 Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_0534
BEL-7402 Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_5492
MHCC97-L Adult hepatocellular carcinoma Homo sapiens (Human) CVCL_4973
MHCC97-H Adult hepatocellular carcinoma Homo sapiens (Human) CVCL_4972
In Vivo Model HCC cells were cultured, and the cells were injected subcutaneously into nude mice, antitumor agents were intragastrically administered 2–3 days after injection of HCC cells.
Result Our data show that SREBP-1 inhibition facilitated the antitumor effects of Sorafenib on HCC cells and xenograft tumors.
03. Reference
No. Title Href
1 SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity. Cell Death Dis. 2019 Sep 11;10(9):672. doi: 10.1038/s41419-019-1884-7. Click
It has been 46850 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP